NCT07278648
High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department
StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 12 months later.
See at-risk trials from Consorci Sanitari de l'Alt Penedès i Garraf
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Mar 1, 2026 to Mar 1, 2027
- Start date: Feb 5, 2026 to Feb 5, 2027
- Eligibility criteria expanded, about 3 words
- Notable Start date: Dec 5, 2025 to Feb 5, 2026v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Hemorragic event
Timeframe: Day 90 from baseline
Arms and interventions
Anticoagulant therapy
Patients who has been discharged from hospital with anticoagulant therapy
Other: Antithrombotic therapy
Sites
1 site in 1 country
- Hospital de VilafrancaVilafranca del Penedès, Barcelona, Spain